Strategic Investments (Details) - USD ($) |
3 Months Ended | 9 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Dec. 18, 2024 |
Nov. 13, 2023 |
Jun. 28, 2025 |
Jun. 29, 2024 |
Jun. 28, 2025 |
Jun. 29, 2024 |
Sep. 28, 2024 |
|
| Schedule of Equity Method Investments [Line Items] | |||||||
| Impairment loss | $ 0 | $ 0 | $ 0 | $ 0 | |||
| Equity securities without readily determinable fair value | 53,300,000 | 53,300,000 | $ 25,300,000 | ||||
| Maverix Medical LLC | |||||||
| Schedule of Equity Method Investments [Line Items] | |||||||
| Payments to acquire equity method investments | $ 24,500,000 | ||||||
| Ownership percentage | 45.00% | ||||||
| Equity method investments | 24,000,000 | 24,000,000 | |||||
| Loss from equity method investments | $ 2,500,000 | $ 5,900,000 | |||||
| Capital call notice, percent of committed capital | 13.30% | ||||||
| Committed capital | $ 9,000,000 | ||||||
| X | ||||||||||
- Definition Capital Call Notice, Percent Of Committed Capital No definition available.
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss on investment in equity security without readily determinable fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of funds committed to investment company from investors. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|